TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.81−0.10 (-5.24%)
Close on Nov 18, 2026Market cap $20.95MP/E –Yield –
TherapeuticsMD free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
TherapeuticsMD's free cash flow for the twelve months ending Sep 30, 2022 was $27.10M. For fiscal 2021 it was -$55.17M. The highest annual figure on record is -$5.00M in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$55.17M | – |
| FY2020 | Dec 31, 2020 | -$159.68M | – |
| FY2019 | Dec 31, 2019 | -$168.17M | – |
| FY2018 | Dec 31, 2018 | -$107.03M | – |
| FY2017 | Dec 31, 2017 | -$76.22M | – |
| FY2016 | Dec 31, 2016 | -$69.54M | – |
| FY2015 | Dec 31, 2015 | -$79.21M | – |
| FY2014 | Dec 31, 2014 | -$45.55M | – |
| FY2013 | Dec 31, 2013 | -$20.81M | – |
| FY2012 | Dec 31, 2012 | -$12.80M | – |
| FY2011 | Dec 31, 2011 | -$5.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | $17.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.70M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.91M | – |
| Q4 FY2021 | Dec 31, 2021 | $48.00M | – |
| Q3 FY2021 | Sep 30, 2021 | -$38.15M | – |
| Q2 FY2021 | Jun 30, 2021 | -$26.57M | – |
| Q1 FY2021 | Mar 31, 2021 | -$38.44M | – |
| Q4 FY2020 | Dec 31, 2020 | -$30.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$55.96M | – |
| Q1 FY2020 | Mar 31, 2020 | -$39.13M | – |
| Q4 FY2019 | Dec 31, 2019 | -$51.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$27.22M | – |
| Q2 FY2019 | Jun 30, 2019 | -$51.34M | – |
| Q1 FY2019 | Mar 31, 2019 | -$38.43M | – |
| Q4 FY2018 | Dec 31, 2018 | -$28.30M | – |
| Q3 FY2018 | Sep 30, 2018 | -$34.09M | – |
| Q2 FY2018 | Jun 30, 2018 | -$24.97M | – |
| Q1 FY2018 | Mar 31, 2018 | -$19.68M | – |
| Q4 FY2017 | Dec 31, 2017 | -$20.83M | – |
| Q3 FY2017 | Sep 30, 2017 | -$16.68M | – |
| Q2 FY2017 | Jun 30, 2017 | -$18.15M | – |
| Q1 FY2017 | Mar 31, 2017 | -$20.55M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.71M | – |
| Q3 FY2016 | Sep 30, 2016 | -$18.84M | – |
See a number that looks wrong?